Videos

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Joe Lipari, director of product management, Systech, describes the latest state of DSCSA implementation guidelines.

Navigating DSCSA Delays

Articles

A qualitative analysis consisting of patients, care partners, and oncology clinicians measures the sources of time burdens, along with how these impact various individuals.

Measuring Time Burdens Around Cancer Care

Dr. Reddy’s immuno-oncology drug for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma will be marketed under the brand name Zytorvi.

Toripalimab Launches in India

The agreement provides PTC with $1 billion in cash once deal closes, and is centered around PTC518's development, manufacturing and commercialization.

PTC Therapeutics, Novartis Sign License and Collab Deal for Huntington’s Disease Program

A total of 140 companies are being placed on the Entity List, in an effort to limit China’s effectiveness in the sector. 

United States Protests China’s Semiconductor Chip Industry, Announces Export Restrictions

The transaction reaffirms the CDMO’s interest in growth on a global scale. 

Adragos Pharma Acquires Baccinex, Growing Sterile Manufacturing Services  

Podcasts

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

Nov. 27 is Here: What Does That Mean for DSCSA?

The proposal aims to reduce out-of-pocket costs for a number of weight loss medications by 95%.

Biden-Harris Administration Proposes Expansion to Medicare and Medicaid to Include Weight Loss Medications

Why well-organized documentation is critical at every stage of the process.

Technically Speaking: Quality Documentation is One of the Best Ways to Boost Performance

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, offers advice for effectively being able to adjust plans.

News